• shareIcon

What is the prognosis of Multifocal Motor Neuropathy?

Updated at: Nov 17, 2014
Other Diseases
Written by: Bhadra KamalasananPublished at: Jan 14, 2013
What is the prognosis of Multifocal Motor Neuropathy?

Multifocal motor neuropathy refers to a progressive muscle disorder that is characterised by weakness in the muscle of the hands and legs. An early treatment ensures a better prognosis.

Multifocal motor neuropathy refers to a progressive muscle disorder that is characterised by weakness in the muscle of the hands with there being differences from one side of the body to the other in those particular muscles that are involved. This medical condition is said to affect more men than women and its symptoms include muscles cramping, muscle wasting and involuntary twitching or contractions of the muscles in the legs. The disorder can sometimes be mistaken for amyotrophic laterial sclerosis. Unlike ALS, multifocal motor neuropathy can be treated.

multifocal motor neuropathy

Prognosis

The prognosis of multifocal motor neuropathy depends on how early the diagnosis is made and how fast treatment is sought. It has been observed post treatment that the involvement of muscle strength tends to begin within 3 to 6 weeks. A lot of patients who receive the treatment early on experience only little, if any, disability.

 

Read more articles on Multifocal Motor Neuropathy.

Disclaimer

All possible measures have been taken to ensure accuracy, reliability, timeliness and authenticity of the information; however Onlymyhealth.com does not take any liability for the same. Using any information provided by the website is solely at the viewers’ discretion. In case of any medical exigencies/ persistent health issues, we advise you to seek a qualified medical practitioner before putting to use any advice/tips given by our team or any third party in form of answers/comments on the above mentioned website.

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK